Carmot Therapeutics Enters into Definitive Merger Agreement with Roche Portfolio News / By Karina Tin December 4, 2023
Neurona Therapeutics Presents New Clinical Data from First Cohort in Ongoing Phase I/II Open-Label Trial of NRTX-1001 Cell Therapy for Drug-resistant Mesial Temporal Lobe Epilepsy (MTLE) Portfolio News / By Karina Tin December 1, 2023
Escient Pharamceuticals Initiates Clinical Proof-of-Concept Study of EP262, A First-in-Class Oral MRGPRX2 Antagonist, In Atopic Dermatitis Portfolio News / By Karina Tin November 28, 2023
RAPT Therapeutics Announces Publication of Phase 1A/1B Clinical Trial of Zelnecirnon (RPT193) To Treat Atopic Dermatitis In Allergy Portfolio News / By Karina Tin November 27, 2023
Carmot Therapeutics Commenced Phase 2 Clinical Trial of Novel Dual GLP-1/GIP Receptor Agonist CT-868 for the Treatment of Type 1 Diabetes Portfolio News / By Karina Tin November 15, 2023
RAPT Therapeutics Reports Third Quarter 2023 Financial Results Portfolio News / By Karina Tin November 13, 2023
NGM Bio Presents Positive Phase 2b Results from the ALPINE 4 Trial of Aldafermin in Patients with Compensated Cirrhosis (F4) Due to NASH at AASLD The Liver Meeting® Portfolio News / By Karina Tin November 13, 2023
Kallyope and Sosei Heptares Nominate First GPCR Target for Therapeutic Development in Gastrointestinal Diseases Portfolio News / By Karina Tin November 10, 2023
Tenaya Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update Portfolio News / By Karina Tin November 8, 2023
ORIC Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Updates Portfolio News / By Karina Tin November 6, 2023
